EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework

Rita Pinto iD, Hege Marie Vedeld, Guro Elisabeth Lind iD, Marine Jeanmougin

Molecular Oncology · 2025-04 · 19 (4) · 1117-1131

DOI: 10.1002/1878-0261.13772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 18.12.2024. Verfasst von Rita Pinto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Adenocarcinoma, Gastrointestinal Neoplasms, Epigenesis, Genetic, Genetic Heterogeneity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kreftforeningen, Helse Sør-Øst RHF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we propose an alternative approach for stratifying genome‐scale DNA methylation profiles of gastrointestinal (GI) adenocarcinomas based on a robust analytical framework. A set of 978 GI adenocarcinomas and 120 adjacent normal tissues from public repositories was quality controlled and analyzed. Hierarchical consensus clustering of the tumors, based on differential epigenetic variability between malignant and normal samples, identified six distinct subtypes defined either by a pan‐GI or a lower GI‐specific phenotype. In addition to methylation levels, aberrant methylation frequencies and the degree of DNA methylation instability contributed to the characterization of each subtype. We found significant differences in the outcome of patients, with the poorest overall survival seen for those belonging to a pan‐GI subtype with infrequent aberrant methylation. In conclusion, our standardized approach contributes to a refined characterization of the epigenetic heterogeneity in GI adenocarcinomas, offering insights into subtype‐specific methylation with the potential to support prognostication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaGastrointestinal NeoplasmsEpigenesis, GeneticGenetic HeterogeneityHumansDNA MethylationFemaleMaleMiddle AgedPrognosisAgedCluster Analysis

Stichwörter der Autor:innen

DNA methylationdifferential variabilitymolecular subtyping

Autor:innen und Institutionen

  • Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital - Norwegian Radium Hospital, Oslo, Norway.
  • Department of Biosciences, The Faculty of Mathematics and Natural Sciences, University of Oslo, Norway.

ORCID-Profile: Rita Pinto, Guro Elisabeth Lind

Förderung

  • Kreftforeningen
  • Helse Sør-Øst RHF

Zitieren

APA

Pinto, R., Vedeld, H. M., Lind, G. E., & Jeanmougin, M. (2025). Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework. Molecular Oncology, 19(4), 1117-1131. https://doi.org/10.1002/1878-0261.13772

Vancouver

Pinto R, Vedeld HM, Lind GE, Jeanmougin M. Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework. Molecular Oncology. 2025;19(4):1117-1131. doi:10.1002/1878-0261.13772

BibTeX
@article{Pinto2025,
  author = {Pinto, Rita and Vedeld, Hege Marie and Lind, Guro Elisabeth and Jeanmougin, Marine},
  title = {Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework},
  journal = {Molecular Oncology},
  year = {2025},
  volume = {19},
  number = {4},
  pages = {1117--1131},
  doi = {10.1002/1878-0261.13772}
}
Kostenlos starten →